Cannabix files US provisional patent for point-of-care THC breath test method

PUBT · 1d ago
Cannabix files US provisional patent for point-of-care THC breath test method
  • Cannabix Technologies filed a U.S. provisional patent application for a rapid point-of-care marijuana breath test targeting delta-9 THC.
  • Method combines its Breath Collection Unit and Breath Cartridge with lateral-flow testing to concentrate standardized breath samples for faster screening.
  • Program targets on-site results within minutes, aimed at workplace or safety screening where recent cannabis use is a focus.
  • Positive screens would be followed by chain-of-custody collection for lab confirmation using LC-MS under its existing Marijuana Breath Test process.
  • Company flagged early-stage development, citing sensitivity and workflow integration work still required.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cannabix Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610140845PRIMZONEFULLFEED9845190) on October 14, 2026, and is solely responsible for the information contained therein.